Brinker Capital Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Brinker Capital Investments’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,471	Closed	-$2.11M	–	1423
2022 Q2	$2.11M	Buy	14,471 +3,038	+27%	+$388K	0.04%	458
2022 Q1	$1.36M	Sell	11,433 -1,319	-10%	-$165K	0.02%	679
2021 Q4	$1.76M	Buy	12,752 +8,780	+221%	+$1.12M	0.03%	620
2021 Q3	$386K	Hold	3,972	–	–	0.01%	1058
2021 Q2	$386K	Buy	3,972 +58	+1%	+$4.71K	0.01%	1111
2021 Q1	$268K	Sell	3,914 -668	-15%	-$54K	﹤0.01%	1083
2020 Q4	$393K	Buy	+4,582	New	+$388K	0.01%	884

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brinker Capital Investments's BHVN Position: Q3 2022 in Review

Brinker Capital Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 14,471 shares — an estimated $2.11M sold.

Brinker Capital Investments first reported a position in BHVN in Q4 2020 and held it in 7 quarters. The position peaked at $2.11M in Q2 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Brinker Capital Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Brinker Capital Investments sold 14,471 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $2.11M.
Brinker Capital Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020 and held it in 7 quarters.
Brinker Capital Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.11M in Q2 2022.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Brinker Capital Investments's 13F filing for Q3 2022, filed 1 Nov 2022.